Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial

Fig. 1

Rates of Gram-positive resistant phenotypes collected from Latin America by year, 2004–2015. MRSA N values: 2004, 30/66; 2005, 131/266; 2006, 247/512; 2007, 258/535; 2008, 374/821; 2009, 479/924; 2010, 325/625; 2011, 57/108; 2012, 47/99; 2013, 55/145; 2014, 60/111; 2015, 139/351. PR S. pneumoniae N values: 2004, 2/41; 2005, 10/123; 2006, 19/178; 2007, 30/232; 2008, 49/269; 2009, 43/258; 2010, 14/91; 2011, 6/52; 2012, 0/14; 2013, 8/49; 2014, 9/44; 2015, 8/85. VR E. faecium N values: 2004, 8/13; 2005, 9/12; 2006, 24/65; 2007, 22/55; 2008, 60/117; 2009, 40/138; 2010, 25/78; 2012, 5/12; 2013, 16/26; 2014, 7/13; 2015, 17/39. Data point for VR E. faecium for 2011 omitted as N < 10. VR E. faecalis N values: 2004, 0/25; 2005, 7/104; 2006, 4/231; 2007, 6/216; 2008, 2/404; 2009, 7/389; 2010, 0/258; 2011, 0/40; 2012, 2/46; 2013, 0/71; 2014, 0/56; 2015, 5/164. MRSA methicillin-resistant S. aureus, PR penicillin-resistant, VR vancomycin-resistant

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us